DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Abbott Laboratories (NYSE: ABT)

44.76 -0.50 (-1.10%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ABT $44.76 -1.10%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.40
Previous Close $45.26
Daily Range $44.70 - $45.63
52-Week Range $35.80 - $46.50
Market Cap $67.4B
P/E Ratio 22.86
Dividend (Yield) $0.96 (2.1%)
Ex-Dividend Date
Dividend Pay Date
10/10/14
11/15/14
Volume 9,613,315
Average Daily Volume 5,273,154
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website: http://www.abbott.com/

News & Commentary

Can You Guess What Legal Drug Outsells the NFL?

The NFL is unquestionably one of the most successful American businesses of all-time. Surprisingly, though, the NFL's 2013 revenues were no match for this single legal drug.

Company News for January 30, 2015 - Corporate Summary

Zacks Rank #5 Additions for Friday - Tale of the Tape

Abbott Reports Solid Q4 Results On Growth Across Divisions

Abbott Laboratories (ABT) Stock Upgraded Today at Bank of America/Merrill Lynch

Abbott Launches New Options for People with Cataracts in the United States

Analysts' Actions: Abbott, Groupon, Procter & Gamble, Visa, More

Top Analyst Upgrades and Downgrades: Cameron, Dollar General, Genworth, Groupon, SunPower, Visa, Yah

Top Analyst Upgrades and Downgrades: Cameron, Dollar General, Genworth, Groupon, SunPower, Visa, Yahoo and More

Best Dividend Stocks for Bear Markets

Abbott Laboratories' (ABT) CEO Miles White on Q4 2014 Results - Earnings Call Transcript

See More ABT News...

ABT's Top Competitors

ABT $44.76 (-1.10%)
Current stock: ABT
RHHBY $33.78 (-1.75%)
Current stock: RHHBY
JNJ $100.14 (-2.19%)
Current stock: JNJ
PFE $31.25 (-1.82%)
Current stock: PFE